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Abstract Here we report that photoactivated hypericin can
induce either apoptosis or necrosis in HeLa cells. Under
apoptotic conditions the cleavage of poly(ADP-ribose) polymer-
ase (PARP) into the 85-kDa product is blocked by the caspase
inhibitors benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone
(z-VAD-fmk) and benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoro-
methylketone (z-DEVD-fmk). Both inhibitors protect cells from
apoptosis but cannot prevent hypericin-induced necrosis. Con-
versely, HeLa cells overexpressing the viral cytokine response
modifier A (CrmA), which inhibits caspase-1 and -8, still undergo
hypericin-induced apoptosis and necrosis. Evidence is provided
for the release of mitochondrial cytochrome c in the cytosol and
for procaspase-3 activation in the hypericin-induced cell killing.
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1. Introduction
Cell death can be induced via two mechanisms: apoptosis
or necrosis. Necrosis, which occurs in response to chemical
and physical insults, leads to an increase in cytoplasmic vol-
ume, swelling of mitochondria and loss of plasma membrane
integrity. The consequential release of the intracellular content
into the extracellular milieu evokes in£ammatory reactions. In
contrast, apoptosis is a gene regulated cell death, which is
characterized by cytoplasmic and nuclear shrinkage, mem-
brane blebbing, chromatin condensation and genomic DNA
fragmentation [1]. Recent work from many laboratories has
validated the critical role of caspases in the execution of apop-
tosis. In the TNF- and Fas-induced apoptosis, caspase-8 is
directly activated upon recruitment to either the TNF-R1 or
Fas receptor signalling complex and initiates a cascade of
proteolytic events, eventually leading to the activation of pro-
caspase-3, one of the downstream executors of the apoptotic
process [2]. Alternatively, procaspase-3 can be activated via
receptor-independent pathways [3].
Photodynamic therapy (PDT) is a relatively new therapeut-
ical approach for the treatment of super¢cial skin and mu-
cosal cancers. The therapy involves the use of a photosensi-
tizer, which is activated by local irradiation, and subsequently
produces reactive oxygen species (ROS), ultimately leading to
cell death [4]. PDT with several photosensitizers has been
shown to induce both apoptosis and necrosis, in vitro as
well as in vivo [4]. Hypericin is a photoactive pigment synthe-
sized by members of the plant genus Hypericum. Hypericin
exhibits in vitro antineoplastic activity [5,6] and we have re-
cently reported that certain human tumors can be successfully
treated with photoactivated hypericin [7,8]. We considered it
of major interest to characterize the molecular mechanism(s)
underlying hypericin-mediated cell photokilling.
Here, we report that photoactivated hypericin can induce
either apoptosis or necrosis in HeLa cells. Both the broad-
spectrum caspase inhibitor z-VAD-fmk and the caspase-3-like
caspase inhibitor z-DEVD-fmk [9] e⁄ciently protected cells
from hypericin-induced apoptosis while neither one of them
had any e¡ect on the hypericin-mediated necrosis. In contrast,
HeLa cells stably transfected with the viral cytokine response
modi¢er A (CrmA), a serpin-like speci¢c caspase-1 and -8
inhibitor [9], were still sensitive to both hypericin-induced
apoptosis and necrosis. In addition, we found that cyto-
chrome c is released in the cytosol of cells photosensitized
by hypericin and that procaspase-3 becomes activated.
2. Materials and methods
2.1. Cell culture
HeLa cells (American Type Culture Collection, Rockville, MD,
USA) and transfected HeLa cells expressing CrmA (CrmA-HeLa)
or the empty vector (Hyg-HeLa) obtained as described in [10], were
grown at 37‡C in Dulbecco’s Modi¢ed Eagle Medium containing L-
glutamine (2 mM), penicillin (100 IU/ml), streptomycin (100 Wg/ml)
and 10% fetal calf serum. All the culture medium components were
obtained from Gibco-BRL (Paisley, Scotland, UK).
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2.2. Cell photosensitization
Hypericin was prepared and used in cell culture experiments as
described earlier [11,12]. Cells were incubated in subdued light con-
ditions with hypericin for 16 h and irradiated with a light dose of 4 J/
cm2 in hypericin free medium.
2.3. Assessment of cell viability and morphology
Cells were seeded onto Lab-Tek Chamber slides (Nalge Nunc In-
ternational, Naperville, IL, USA). Cell viability was estimated by
trypan blue exclusion. Dead cells were counted in at least 10 micro-
scopic ¢elds with a minimum of 50 cells per ¢eld and expressed as
percentage of dead cells over the total number of cells.
2.4. Nuclear fragmentation
Subcon£uent cells, grown on Lab-Tek Chamber slides and treated
as described before, were ¢xed in 100% cold methanol for 20 min,
washed with PBS and stained with Hoechst 33342 (Sigma). The sam-
ple was then examined using a £uorescence microscope (Nikon).
Apoptotic nuclei were counted in at least 10 ¢elds with a minimum
of 50 cells per ¢eld and expressed as a percentage of apoptotic nuclei
over the total number of nuclei.
2.5. DNA fragmentation
Following photosensitization, 2.5U106 cells were washed with ice
cold PBS, scraped and lyzed in 1 ml lysis bu¡er containing 100 mM
NaCl, 10 mM Tris-HCl, pH 8, 25 mM EDTA and 0.5% SDS. After a
centrifugation step, the supernatant was incubated for 2 h at 56‡C
with 0.2 mg/ml proteinase K. The DNA was precipitated with 2 vol-
umes of absolute ethanol, resuspended in TE-bu¡er (10 mM Tris, pH
8, 1 mM EDTA) and treated for 1 h with 1 mg/ml DNase-free RNase
prior to loading onto a 1.5% agarose gel. After electrophoresis, the
DNA was stained with ethidium bromide and visualized under UV.
2.6. Western blotting
Following photosensitization, cells (1.5U106) were collected and
washed with ice-cold PBS. For PARP or procaspase-3 analysis, cells
were lyzed in bu¡er A containing 1% Triton X-100 [13]. Cell lysates
for cytochrome c analysis were made in PBS with 0.02% (w/v) dig-
itonin (Boehringer Mannheim, Germany) and 1 mM EDTA. After
lysis, cells were collected, homogenized and centrifuged. Pellets of
cell lysates made in digitonin-containing lysis bu¡er were resuspended
in 200 Wl lysis bu¡er A and re-processed as described. These samples
were used as positive controls for the detection of mitochondrial cy-
tochrome c. Samples were separated by SDS-PAGE and electropho-
retically transferred to polyvinylidene di£uoride (PVDF) membranes
(Bio-Rad, Hercules, CA, USA). The blots were blocked overnight at
4‡C in TBST bu¡er (50 mM Tris, pH 7.4, 150 mM NaCl, 0.1%
Tween-20) containing 5% non-fat dry milk and then incubated for
2 h at room temperature with either anti-PARP (Biomol Research
Labs., Plymouth, PA, USA), anti-cytochrome c (Pharmingen, San
Diego, CA, USA) or anti-caspase-3 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) antibodies. Detection was carried out with the en-
hanced chemiluminescence detection system (ECL, Amersham Inter-
national, UK).
2.7. Cell proliferation
Cells were seeded onto 24-well tissue culture plates (Falcon) at
2U104 cells per well, and incubated at 37‡C. After adherence, cells
were treated with hypericin as described before. The caspase inhibitors
z-VAD-fmk and z-DEVD-fmk (Enzyme Systems Products, Liver-
more, CA, USA) were added under subdued light conditions 2 h
before irradiation and re-added every 24 h. At each time point, cell
proliferation was determined by quanti¢cation of the cellular protein
content using naphthol blue black (Acros, Beerse, Belgium) as de-
scribed in [14]. The absorbance was measured at 620 nm using a
microtiter plate reader (SLT, Salzburg, Austria).
3. Results
3.1. Hypericin can induce either apoptosis or necrosis in
HeLa cells
Recently, we reported that hypericin causes photocytotox-
icity in di¡erent human cancer cell lines [6,12]. Using HeLa
cells as a model system, we investigated in more detail the
type of the hypericin-induced cell death, i.e. apoptosis or ne-
crosis. HeLa cells were incubated for 16 h under strictly sub-
dued light conditions with di¡erent concentrations of hyper-
icin ranging from 80 nM to 10 WM. Cells were subsequently
irradiated and all further incubations were done in dark con-
ditions. The type of cell death was evaluated over a 72-h
period, using di¡erent criteria. Cells incubated with 80 to
250 nM photoactivated hypericin showed distinctive apoptotic
features as shown in Fig. 1. As indicated by the incorporation
of trypan blue (Table 1), most of the cells lost their membrane
integrity only 24 h after irradiation. Cell death was strictly
light- and hypericin-dependent, since HeLa cells treated with
similar amounts of hypericin and protected from light were
not a¡ected (data not shown). Nuclear staining with Hoechst
33342 con¢rmed that cells treated with 125 nM photoacti-
vated hypericin were apoptotic, as demonstrated by their con-
densed and fragmented nuclei (Fig. 1). The percentage of
apoptotic nuclei was 50% 24 h after irradiation and further
increased up to 74% within 48 h (Table 1). In contrast, HeLa
cells exposed to v1 WM hypericin died very fast after irradi-
ation, as shown by trypan blue uptake (Table 1). This type of
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Fig. 1. Photoactivated hypericin can induce apoptosis or necrosis in HeLa cells. Phase-contrast microscopic analysis (a^c) and nuclear Hoechst
33342 staining (d^f) of control cells (a, d) and cells treated with either 125 nM (b, e) or with 1 WM hypericin (c, f) for 16 h. Cells were then ex-
posed to light for 15 min at 4.5 mW/cm2, to give a total dose of 4 J/cm2 and analyzed 24 h post-irradiation as described in Section 2.
A. Vantieghem et al./FEBS Letters 440 (1998) 19^2420
hypericin-induced cytotoxicity was considered as necrotic cell
death since cells appeared swollen and nuclei were clearly
enlarged with no sign of nuclear fragmentation (Fig. 1).
Although some kind of membrane blebbing could be observed
immediately after irradiation (not shown), this was clearly
stopped by the progressive cell swelling (Fig. 1). DNA frag-
mentation analysis by agarose gel electrophoresis showed a
signi¢cant time-dependent increase in the amount of low mo-
lecular weight DNA extracted from cells treated with 125 nM
photoactivated hypericin. No fragmentation was observed
when 1 WM photoactivated hypericin was used (Fig. 2). It
should be mentioned that despite numerous e¡orts, using dif-
ferent protocols, no clear DNA laddering could be visualized
in apoptotic HeLa cells, an observation which has also been
reported by others using di¡erent apoptotic stimuli [15].
3.2. Mechanism of hypericin-induced cell death
Caspase-mediated poly(ADP-ribose) polymerase (PARP)
cleavage is considered to be a hallmark of the execution of
the apoptotic program [16]. Fig. 3A shows a Western blot
analysis of the time course of PARP cleavage in apoptotic
and necrotic cell death induced by photoactivated hypericin.
Untreated control cells and cells exposed to hypericin but not
irradiated revealed only a single protein band at 116 kDa,
which corresponds to the intact PARP protein (Fig. 3A, lanes
1, 2 and 5). Cells exposed to photoactivated hypericin under
apoptotic conditions (Fig. 3A, lanes 3, 4) showed the charac-
teristic 85-kDa PARP cleavage product which started to ac-
cumulate between 3 and 7 h after irradiation. The cleavage
was complete 48 h after irradiation, a time point at which also
a profound DNA fragmentation was observed (Fig. 2). In
lysates of cells treated with 1 WM hypericin the full size
PARP protein could be still detected 1 h post-irradiation
(Fig. 3, lane 7), albeit after that time-period approximately
90% of the cells incorporated trypan blue (Table 1). After
prolonged post-irradiation periods, both the intact PARP pro-
tein and its cleaved product became hardly detectable by the
anti-PARP antibody (Fig. 3A, lanes 8, 9). Although an equal
amount of proteins was loaded for Western blot analysis, it is
possible that the de¢cient PARP detection is due to selective
protein losses resulting from cell lysis during necrosis.
Since caspases are activated by hypericin treatment, as dem-
onstrated by the speci¢c PARP cleavage, we investigated
whether the cell-permeable synthetic caspase inhibitors z-
VAD-fmk and z-DEVD-fmk and the serpin-like inhibitor, vi-
ral cytokine response modi¢er A (CrmA), could in£uence the
hypericin-induced cell death. Microscopic evaluation of the
cells treated with either z-VAD-fmk or z-DEVD-fmk in com-
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Fig. 2. Time-dependent DNA fragmentation following hypericin
photosensitization of HeLa cells. Control cells (lane 1) and cells
treated with either 125 nM (lanes 2^4) or 1 WM (lane 5) photoacti-
vated hypericin (4 J/cm2) were processed for DNA fragmentation
analysis at the indicated time periods post-irradiation (p.i.).
Fig. 3. Induction of PARP cleavage by photoactivated hypericin. A:
Time-dependent proteolytic PARP cleavage by 125 nM (lanes 2^4)
or 1 WM (lanes 5^9) photoactivated hypericin (4 J/cm2). Controls
are: lane 1, untreated cells ; lanes 2 and 5, cells treated with 125
nM and 1 WM hypericin, respectively, without irradiation. Cell ly-
sates were prepared at the indicated time post-irradiation (p.i.), sub-
jected to SDS-PAGE and transferred to PVDF membranes. Blots
were then probed with polyclonal anti-PARP antibody and revealed
by ECL. B: PARP cleavage induced by apoptotic concentration of
photoactivated hypericin is blocked by z-VAD-fmk and z-DEVD-
fmk. Cells were treated with 125 nM hypericin (lanes 2^4) or with
1 WM hypericin (lanes 5 and 6). z-VAD-fmk (100 WM) and z-
DEVD-fmk (100 WM) were added 2 h prior to light exposure
(4 J/cm2). Cells were lyzed 24 h after irradiation and processed as
in A.
Table 1
Time course of cytotoxicity induced by photoactivated hypericin in HeLa cells
Time post irradiation 125 nM hypericin 1 WM hypericin
% dead cells % apoptotic nuclei % dead cells % apoptotic nuclei
1 h 1.9 þ 0.7 n.d. 91 þ 2 0
7 h 7.2 þ 3 n.d. 100 0
24 h 32 þ 5 50 þ 4 100 0
48 h 70 þ 32 74 þ 7 100 0
The percentage of dead cells was evaluated by trypan blue uptake and apoptotic nuclei were scored after Hoechst 33342 staining as described in
Section 2. Results are means of independent determinations (ns 3) and the standard deviation is indicated. n.d. = not determined.
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bination with 125 nM photoactivated hypericin showed an
increased survival of cells as compared to control cells. Addi-
tion of either z-VAD-fmk or z-DEVD-fmk prior to irradiation
reduced the number of apoptotic nuclei, as judged by Hoechst
33342 staining (Fig. 4), from approximately 80% to less than
25%. The pretreatment with z-DEVD-fmk particularly af-
fected the apoptotic morphological changes by drastically
counteracting membrane blebbing (not shown). These obser-
vations together with the inhibitory e¡ect on the hypericin-
induced PARP cleavage (Fig. 3B, lanes 3 and 4), suggest that
the anti-apoptotic or protective action of z-VAD-fmk and z-
DEVD-fmk is the result of caspase inhibition. No e¡ect of z-
VAD-fmk or z-DEVD-fmk was observed when cells were ex-
posed to necrotic concentrations of photoactivated hypericin
(not shown). Moreover, the loss or degradation of full size
PARP under necrotic conditions was not a¡ected by the pres-
ence of caspase-inhibitors (Fig. 3B, lane 6).
The role played by the caspases-1 and -8 in the hypericin
induced cell death, was addressed using CrmA-overexpressing
HeLa cells. Cells expressing the empty vector, as selected by
hygromycin (Hyg-HeLa), were used as control cells. In con-
trast to what was found with the peptide caspase inhibitors,
the CrmA-overexpressing HeLa cells were still killed by apop-
totic concentrations of photoactivated hypericin, while being
resistant to TNF- and Fas-induced apoptosis (not shown).
As shown in Fig. 5A, both z-VAD-fmk and z-DEVD-fmk
e⁄ciently counteracted cell death and completely restored cell
growth 24 h post-irradiation, but they only partially prevented
cell growth inhibition 48 and 72 h after irradiation. It should
be noted that the inhibitors themselves did not a¡ect the level
of cell proliferation (data not shown). As shown in Fig. 5B,
there were no major di¡erences in the proliferation pattern of
CrmA-overexpressing and Hyg-HeLa cells upon treatment
with photoactivated hypericin.
Taken together, these observations suggest that the hyper-
icin-induced apoptosis is not mediated by caspase-1 or casp-
ase-8, but involves a z-VAD-fmk and z-DEVD-fmk-inhibit-
able caspase activity. This would also suggest that the death
domain receptors, such as Fas or TNF-R1, are less likely to
be involved in hypericin-induced apoptosis since these cyto-
toxic activities are sensitive to CrmA inhibition (data not
shown and [17,18]).
3.3. Photoactivated hypericin induces release of cytochrome c
and activation of procaspase-3
Apoptosis induced by di¡erent agents coincides with the
release of cytochrome c from mitochondria into the cytosol,
where it acts as a cofactor in the activation of procaspase-9,
eventually leading to procaspase-3 activation [3]. Our obser-
vation that z-DEVD-fmk does inhibit hypericin-induced
apoptosis suggests that a caspase-3-like activity could be in-
volved. As shown in Fig. 6 (lanes 2^4), apoptotic concentra-
tions of photoactivated hypericin triggered the mitochondrial
release of cytochrome c into the cytosol of HeLa cells in a
time-dependent manner. The cytochrome c accumulated in the
cytosol of photosensitized cells as early as 1 h post-irradiation
and remained detectable for up to 24 h. The release of cyto-
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Fig. 5. Proliferation pattern of photoactivated hypericin-treated
HeLa cells in the presence of caspase inhibitors. Panel A: HeLa
cells were incubated or not (control) with 125 nM hypericin for 16
h. z-VAD-fmk (100 WM) and z-DEVD-fmk (100 WM) were added
2 h before exposing the cells to light (4 J/cm2). Following irradia-
tion, cells were incubated in the dark and cell proliferation deter-
mined at the indicated time periods. Panel B: Hyg-HeLa cells (Hyg)
and CrmA-overexpressing HeLa cells (CrmA) were incubated or not
(controls) with 250 nM hypericin for 16 h, irradiated and processed
as in A. Results are the mean values of 3 independent determina-
tions and vertical bars indicate the standard deviation.
Fig. 4. The caspase inhibitors z-VAD-fmk and z-DEVD-fmk protect
HeLa cells from photoactivated hypericin-induced apoptosis. Fluo-
rescent microscopic analysis of HeLa cell nuclei stained with
Hoechst 33342 24 h post-irradiation. Untreated cells (a) and cells
treated with 125 nM hypericin (b^d) for 16 h. Two hours before
light exposure (4 J/cm2) cells were incubated with either 100 WM z-
VAD-fmk (c) or 100 WM z-DEVD-fmk (d).
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chrome c was observed between 1 and 7 h following irradi-
ation, clearly preceding the onset of PARP cleavage (Fig. 3A).
Surprisingly, when we increased the concentration of hyper-
icin to 1 WM to produce the necrotic response, we still could
detect a very fast cytochrome c release (Fig. 6, lanes 5^8).
Under these conditions, the released cytochrome c was ob-
served immediately following cell photosensitization (not
shown), thus before necrotic destruction of the cell had al-
ready occurred.
We next investigated whether the release of cytochrome c in
the cytosol was accompanied by the activation of procaspase-
3. As shown in Fig. 7 apoptotic concentrations of photoacti-
vated hypericin induced the cleavage of the 32-kDa procasp-
ase-3 into its 11-kDa active fragment. This observation to-
gether with the inhibitory e¡ect of z-DEVD-fmk on the
apoptotic program (see Figs. 3^5), suggests that caspase-3 is
a key mediator of the hypericin-induced apoptosis in HeLa
cells.
4. Discussion
In this study we report that the type of hypericin-induced
cell photokilling can be shifted from apoptosis to necrosis by
increasing the concentration of hypericin applied to the cells
(Figs. 1 and 2). The cellular response to 125 nM photoacti-
vated hypericin is largely, if not exclusively, apoptotic. In-
creasing the hypericin concentration to 1 WM leads to ne-
crosis. A shift from an apoptotic to a necrotic response, can
be produced by increasing the light dose and by changing the
preincubation time, as it has been reported for the widely used
photosensitizers Photofrin and chloroaluminum phthalocy-
anine [19,20]. Similarly, we have also observed that a conver-
sion from apoptotic to necrotic cell death can be produced by
increasing the light doses applied to the cells in the presence of
nanomolar hypericin concentrations (results not shown). Hy-
pericin-induced apoptosis has been reported in studies dealing
with its inhibitory e¡ect on protein kinase C [21^24]. Unfortu-
nately, in these studies little attention was paid to light and
photosensitization conditions, making the experimental setups
described very di⁄cult to reproduce.
Apoptotic concentrations of photoactivated hypericin in-
duce a time-dependent cleavage of PARP into the 85-kDa
fragment (Fig. 3A). PARP is one of the nuclear substrates
of the e¡ector caspase-3 and -7 [16]. Fig. 3B illustrates that
the addition of either the broad spectrum caspase inhibitor z-
VAD-fmk or the caspase-3-like inhibitor z-DEVD-fmk prior
to light activation completely prevents the hypericin-induced
PARP fragmentation. These data suggest that caspase-3 and/
or caspase-7 might participate in the apoptotic pathway trig-
gered by photoactivated hypericin in HeLa cells. In necrotic
conditions, the intact PARP protein and its proteolytic frag-
ment were only faintly immunodetectable and the addition of
the former caspase inhibitors could not reverse this e¡ect (Fig.
3A and B).
Interestingly, in two recent studies where the photosensi-
tizer chloroaluminum phthalocyanine was used in di¡erent
cell lines, either preservation of the intact PARP protein [20]
or complete conversion into the 85-kDa fragment [25] was
observed with high (necrotic) PDT doses. Thus it is possible
that excessive cell photosensitization still allows the initiation
of the apoptotic program which is then overruled by the ex-
tensive oxidative stress produced and necrosis occurs either
before or after a caspase-dependent PARP cleavage takes
place.
Besides counteracting PARP cleavage, both caspase inhib-
itors z-VAD-fmk and z-DEVD-fmk e⁄ciently antagonize hy-
pericin-induced apoptosis (Fig. 4) and particularly z-DEVD-
fmk prevents the appearance of membrane blebbing. Con-
versely, HeLa cells overexpressing the serpin-like inhibitor
CrmA, which preferentially targets caspase-1 and -8 [9], are
not protected from the apoptotic action of hypericin. Since
CrmA overexpression e⁄ciently blocks the TNF and Fas-in-
duced apoptotic cell death in this cell line, we can conclude
that hypericin induces apoptosis independently from the
TNF-R1- or Fas-mediated caspase pathway. The proliferation
results shown in Fig. 5 illustrate that the anti-apoptotic e¡ect
of both z-VAD-fmk and z-DEVD-fmk is particularly evident
24 h post-irradiation, while the CrmA overexpressing cells do
not exhibit signi¢cant protection at any time point examined.
However, cells treated with photoactivated hypericin in the
presence of z-VAD-fmk and z-DEVD-fmk seem to have lost
their proliferative potential, as shown by the cytostatic e¡ect
of these inhibitors on cell proliferation at later time points.
Collectively taken, these results clearly show that caspase
function is required for photoactivated hypericin-induced
apoptosis and suggest that a downstream DEVD-caspase ac-
tivity is a key mediator in this process. Moreover, the fact that
none of the three caspase inhibitors used has an e¡ect on
hypericin-mediated necrosis, supports the view that the two
ways of hypericin-induced cell death do not share similar pro-
teolytic activities.
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Fig. 7. Photoactivated hypericin induces procaspase-3 cleavage.
HeLa cells were treated (lanes 2^4) or not (lane 1) with 125 nM hy-
pericin for 16 h. Cells were lyzed at the indicated times following ir-
radiation (4 J/cm2). Cell lysates were subjected to SDS-PAGE,
transferred to PVDF membrane, probed with polyclonal anti-casp-
ase-3 antibodies and revealed by ECL.
Fig. 6. Photoactivated hypericin induces a fast release of cyto-
chrome c in the cytosol. Lysates of HeLa cells photosensitized (4 J/
cm2) by 125 nM (lanes 2^4) or 1 WM (lanes 5^8) hypericin and pre-
pared at the indicated time post-irradiation (p.i.) were subjected to
SDS-PAGE, blotted to PVDF membrane, probed with anti-cyto-
chrome c antibodies and revealed by ECL.
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Recent reports have revealed that the release of the cyto-
chrome c from the mitochondria into the cytosol in response
to di¡erent apoptotic insults, is involved in the proteolytic
activation of procaspase-3 [3]. Very little information is avail-
able on the release of cytochrome c and other mitochondrial
activity changes in cells undergoing necrosis. Fig. 6 shows that
cytochrome c accumulates rather fast and remains detectable
up to 24 h in the cytosol of cells photosensitized by 125 nM
hypericin, but also by 1 WM hypericin. While in both condi-
tions the release of cytochrome c precedes the onset of PARP
cleavage (Fig. 3), nuclear fragmentation occurs only in the
apoptotic condition (Figs. 1 and 2). This suggests that photo-
activation of 1 WM hypericin might initially trigger the apop-
totic program (see also Fig. 3A) which is later overruled by
excessive photodamage. Alternatively, the necrotic cell dam-
age could also lead to the aspeci¢c release of cytochrome c.
The result depicted in Fig. 7 clearly con¢rms that photo-
activated hypericin induces the cleavage and activation of
procaspase-3. Interestingly, procaspase-3 activation was also
observed with the photosensitizer benzoporphyrin derivative
monoacid ring A [26]. Since all the apoptotic activities re-
ported are preferentially blocked by z-DEVD-fmk, we can
conclude that the induction of the apoptotic program by pho-
toactivated hypericin is most likely dependent on caspase-3
activity. Furthermore our data suggest that the release of
the mitochondrial cytochrome c in the cytosol might be the
triggering factor upstream of procaspase-3 activation.
Recently it has been reported that 1 WM photoactivated
hypericin induces a marked and irreversible decrease in the
total cellular ATP levels and in the mitochondrial respiratory
function [27]. This observation suggests that mitochondria are
major targets of hypericin-induced cellular photodamage. The
intracellular ATP level has been recognized as a crucial factor
in determining the cell death fate, and in some instances apop-
totic signals may be converted in necrotic signals when cellu-
lar ATP depletion reaches a critical level [28]. Obviously, fur-
ther studies will be required to identify the upstream events
leading to procaspase-3 activation and the precise role of mi-
tochondria in determining the nature of hypericin-induced cell
death.
During PDT in vivo both necrosis and apoptosis are likely
to be induced and it can be argued that necrosis will occur at
the surface of the tumor where cells will be exposed to a high
light dose whereas interior areas will receive light doses su⁄-
cient to induce apoptosis. For treatment of small size tumors
as in the case of micrometastases, the possibility to discrim-
inate between these two types of cell death might be of ther-
apeutic relevance.
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